Transvaginal Surgical Mesh
Transvaginal surgical mesh products are used to treat patients who suffer from pelvic organ prolapse or stress urinary incontinence. The Food and Drug Administration has warned that patients who have been treated with transvaginal mesh are more likely to experience complications than those who elect to undergo traditional surgical repair.
Surgical mesh was first used for hernia repair surgery beginning in the 1950s. In the 1970s, surgeons began using these products to treat patients with pelvic organ prolapse (POP). In the 1990s, surgical mesh was first used for the treatment of stress urinary incontinence (SUI).
The FDA stated in a January 2012 warning that complications from surgery with transvaginal mesh were more common than the agency had previously believed. Some of the potential complications of surgical mesh include pain, infection, bleeding, organ perforation urinary problems or vaginal mesh erosion at higher rates than patients who elect for traditional surgery.
Based on these findings, the FDA ordered the manufacturers of transvaginal surgical mesh products to gather additional data about the safety of these devices. The agency stated that it would consider plans to restrict sales of transvaginal mesh by requiring a more stringent approval process, although it has not announced any plans to issue a surgical mesh recall.
If you or a loved one underwent surgery with transvaginal mesh and have experienced complications with the device, you may be eligible to file a lawsuit. For a free legal consultation, contact the transvaginal mesh lawyers at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by filling out the free case evaluation form located on the right side of this page.